The valve-in-valve technique: Transcatheter treatment of aortic bioprothesis malposition

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 5, 2009, Pages 713-716

  Ussia, Gian Paolo ^a   Mulè, Massimiliano ^a   Tamburino, Corrado ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Aortic regurgitation; Percutaneous valve; Valve in valve

Indexed keywords

AGED; ANEURYSM SURGERY; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; AORTIC ANNULOPLASTY; AORTOGRAPHY; ARTERY DIAMETER; ARTICLE; CASE REPORT; FALSE ANEURYSM; FEMALE; FUNCTIONAL STATUS; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE BIOPROSTHESIS; HUMAN; IMPLANTATION; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AORTOGRAPHY; BALLOON DILATATION; BIOPROSTHESIS; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RADIOGRAPHY, INTERVENTIONAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 65549143852     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21896     Document Type: Article

References (9)

1. Vahaian A, Alfieri O, Walther T, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;11:1463-1470.
2. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
3. Webb JG, Pasupati S, Humphries K, Lichtenstein S, et al. Percutaneous transarterial aortic valve replacement in selected highrisk patients with aortic stenosis. Circulation 2007;116:755-763.
4. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia GP, Wenaweser P, Windecker S, Laborde JC, de Jaegere1 P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
5. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006;47:1214-1223.
6. Al Ali AM, Altwegg AL, Webb JG, et al. Prevention and management of transcatheter balloon expandable aortic valve malposition. Catheter Cardiovasc Interv 2008;72:573-578.
7. Hanzel GS, O'Neill WW. Complications of percutaneous aortic valve replacement: Experience with the Cribier-Edwards™ percutaneous heart valve. EuroIntervention 2006;1 (Suppl A):A3-A8.
8. Ruiz CE, Laborde JC, Condado JF, Chiam P, et Condado JA. First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up. Catheter Cardiovasc Interv 2008;72: 143-148.
9. Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 2008;71:579-584.